Short answer · Medically reviewed summary · Last updated: 2026-04-07
Evans Syndrome does not have its own unique, dedicated code in the ICD-10 or ICD-9 systems because it is a clinical diagnosis defined by the simultaneous or sequential occurrence of two distinct autoimmune conditions. Clinicians typically use a combination of codes, most commonly ICD-10 D69.3 (Autoimmune thrombocytopenic purpura) and ICD-10 D59.1 (Other autoimmune hemolytic anemias), to accurately document the patient's full clinical profile. What is the clinical definition of Evans Syndrome? Evans Syndrome is a rare, chronic autoimmune disorder characterized by the body’s immune system mistakenly attacking its own red blood cells and platelets.
Evans Syndrome does not have its own unique, dedicated code in the ICD-10 or ICD-9 systems because it is a clinical diagnosis defined by the simultaneous or sequential occurrence of two distinct autoimmune conditions. Clinicians typically use a combination of codes, most commonly ICD-10 D69.3 (Autoimmune thrombocytopenic purpura) and ICD-10 D59.1 (Other autoimmune hemolytic anemias), to accurately document the patient's full clinical profile.
Evans Syndrome is a rare, chronic autoimmune disorder characterized by the body’s immune system mistakenly attacking its own red blood cells and platelets. This leads to two primary conditions: autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Because Evans Syndrome is a diagnosis of exclusion—meaning other underlying illnesses like systemic lupus erythematosus or primary immunodeficiencies must first be ruled out—coding it requires capturing both the anemia and the thrombocytopenia components separately in medical records to ensure accurate billing and clinical documentation.
Since there is no single ICD-10 code for the syndrome itself, healthcare providers use a combination of codes to reflect the complexity of the disease. When managing a patient with Evans Syndrome, the documentation must reflect the dual nature of the cytopenias. Common coding practices include:
Accurate coding is vital not only for insurance reimbursement but also for tracking the prevalence of Evans Syndrome in global health registries. Because the condition is rare—with an estimated prevalence that remains difficult to define precisely due to underdiagnosis—robust documentation helps researchers identify patient cohorts for clinical trials. At DiseaseMaps.org, 110 people with Evans Syndrome have joined our community, sharing their experiences to help others navigate the diagnostic journey and the complexities of long-term treatment management.
While most cases of Evans Syndrome are considered sporadic (occurring without a family history), there is a subset of patients, particularly children, who may have an underlying genetic predisposition. Some patients with Evans Syndrome are found to have mutations in genes involved in immune regulation, such as CTLA4, LRBA, or STAT3. If you are experiencing recurrent episodes, your clinical geneticist may recommend genetic testing to determine if your Evans Syndrome is a manifestation of an underlying primary immunodeficiency disorder.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.